TABLE 5.
Usefulness assessment |
||||||||||||
Exposure |
Status |
Function |
Effect |
|||||||||
Research | Clinical | Program | Research | Clinical | Program | Research | Clinical | Program | Research | Clinical | Program | |
Dietary assessment | + | 0 | + | + | 0 | + | 0 | 0 | 0 | 0 | 0 | + |
Plasma or serum zinc concentration | + | 0 | + | + | 0 | + | + | 0 | + | + | 0 | + |
Stunting | + | 0 | 0 | + | 0 | 0 | + | 0 | + | + | 0 | + |
0, not useful for the specific purpose; +, useful to some extent and in certain population groups but either not commonly used or important disadvantages (e.g., no reference values); ++, useful in certain population groups, often used with some limitations (e.g., lack of specificity or sensitivity); +++, useful, often used in relevant population groups, with no or only minor limitations. None of the 3 recommended zinc biomarkers met the criteria for ++ or for +++.